Workup of Isolated Elevated CK-MB in a Patient on Multiple Antipsychotics
An isolated elevated CK-MB without elevation in troponin, total CK, or CRP is not indicative of myocardial injury and should prompt evaluation for non-cardiac causes, particularly antipsychotic-induced asymptomatic CK elevation, rather than cardiac workup. 1, 2
Understanding the Clinical Context
Troponin is the gold standard for detecting myocardial injury, not CK-MB. 1, 2 When troponin is normal despite elevated CK-MB, this virtually excludes acute myocardial infarction. 1, 3 The ACC/AHA guidelines explicitly state that measurement of total CK is not recommended for diagnosis of MI due to lack of specificity, and CK-MB has significantly lower sensitivity and specificity compared to troponin. 3, 4
CK-MB can be elevated from non-cardiac sources, including skeletal muscle. 5 The European Heart Journal specifically notes that troponins will clarify cardiac involvement when CK-MB is falsely elevated from conditions like skeletal muscle trauma. 5, 2
Antipsychotic-Associated CK Elevation
Multiple antipsychotics are well-documented to cause massive asymptomatic CK elevation (MACKE) without signs of neuroleptic malignant syndrome or rhabdomyolysis. 6, 7, 8 This phenomenon has been reported with:
Key characteristics of antipsychotic-induced CK elevation include: 7, 8
- Onset from 5 days to 2 years after initiating treatment 8
- Duration of 4-28 days (median 8 days) 8
- Often asymptomatic or with only mild flu-like symptoms 7, 8
- Self-limiting in many cases despite continuing treatment 8
- Can recur with rechallenge 8
- CK elevations ranging from 1,206 to 177,363 IU/L 8
Recommended Diagnostic Approach
Initial Assessment
Confirm the isolated nature of the CK-MB elevation by verifying: 9
- Normal troponin (already done - excludes myocardial injury) 1, 2
- Normal total CK (already done - unusual pattern) 9
- Normal CRP (already done - excludes inflammatory myopathy) 10, 9
Perform focused clinical evaluation looking for: 10, 7
- Signs of neuroleptic malignant syndrome: fever, altered consciousness, muscle rigidity, autonomic instability 7
- Signs of rhabdomyolysis: dark urine, severe weakness, flu-like syndrome 10, 7
- Muscle pain, tenderness, or weakness 10, 9
- Recent trauma, intramuscular injections, restraints, or intense physical activity 7
Additional Laboratory Testing
If the patient is asymptomatic and NMS/rhabdomyolysis are excluded, obtain: 10, 9
- Repeat CK-MB and total CK in 2-4 weeks to assess trend 9
- Consider checking myoglobin if concerned about muscle damage 8
- Liver enzymes (AST, ALT, LDH, aldolase) to evaluate for muscle inflammation 10
Do not pursue cardiac workup (ECG, echocardiogram, stress testing) when troponin is normal. 1, 2 The ACC/AHA guidelines state that in the clinical setting of acute ischemia, MI is diagnosed when both troponin AND CK-MB are increased together—not CK-MB alone. 2
Management Strategy
If Patient is Asymptomatic
No immediate intervention is required. 9 The finding likely represents antipsychotic-induced MACKE, which is self-limiting and does not require discontinuation of effective psychiatric medication. 7, 8
Monitor with repeat CK-MB and total CK in 2-4 weeks. 9 If levels normalize or remain stable without symptoms, continue current antipsychotic regimen. 7, 8
If Signs of NMS or Rhabdomyolysis Develop
Immediately discontinue the antipsychotic if the patient develops: 7
- Fever, altered consciousness, or muscle rigidity
- Dark urine (myoglobinuria)
- Severe weakness or very high and persisting CK levels
Urgent referral to internal medicine or neurology is indicated. 10
Regarding Medication Changes
Switching to another antipsychotic is not necessarily safer. 7 Empirical evidence indicates there is no "safe" antipsychotic medication regarding CK elevation, and rechallenge with different agents can reproduce the elevation. 6, 7, 8
If the current antipsychotic regimen is therapeutically effective and the patient is asymptomatic, continuation is reasonable. 7, 8 The spontaneously remitting or intermittent course of MACKE suggests it should be kept distinct from both rhabdomyolysis and NMS. 7
Common Pitfalls to Avoid
Do not diagnose myocardial infarction based on isolated CK-MB elevation when troponin is normal. 1, 2, 11 Studies show that isolated CK-MB elevation without troponin elevation has limited prognostic value and does not identify patients at increased cardiac risk. 11
Do not unnecessarily discontinue an effective antipsychotic for asymptomatic CK elevation. 7, 8 Raising awareness of MACKE may reduce unnecessary diagnoses of NMS or rhabdomyolysis, which can lead to discontinuation of effective therapeutic agents. 7
Do not assume the isolated CK-MB elevation is cardiac in origin. 12 CK-MB can be elevated in patients with myopathy, neuropathy, skeletal muscle injury, or renal failure in the absence of myocardial injury. 12
Routine monitoring of CK is not necessary during antipsychotic treatment. 8 Weekly monitoring is only indicated when there are reasons to believe elevated CK is toxic or harmful, such as signs of NMS or rhabdomyolysis. 7